<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/CINECAstyle.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-24T14:07:13Z</responseDate><request verb="GetRecord" identifier="oai:iris.unica.it:11584/266769" metadataPrefix="oai_dc">https://iris.unica.it/oai/request</request><GetRecord><record><header><identifier>oai:iris.unica.it:11584/266769</identifier><datestamp>2022-10-20T09:22:54Z</datestamp><setSpec>com_11584_207615</setSpec><setSpec>com_11584_111066</setSpec><setSpec>col_11584_265854</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Theranostic applications of fluorescent liquid crystalline nanoparticles</dc:title>
<dc:creator>MELI, VALERIA</dc:creator>
<dc:subject>antineoplastic drugs</dc:subject>
<dc:subject>cubosomes</dc:subject>
<dc:subject>cubosomi</dc:subject>
<dc:subject>esosomi</dc:subject>
<dc:subject>farmaci antineoplastici</dc:subject>
<dc:subject>hexosomes</dc:subject>
<dc:subject>monoolein</dc:subject>
<dc:subject>monooleina</dc:subject>
<dc:subject>nanomedicina</dc:subject>
<dc:subject>nanomedicine</dc:subject>
<dc:subject>teranostica</dc:subject>
<dc:subject>theranostic</dc:subject>
<dc:subject>Settore CHIM/02 - Chimica Fisica</dc:subject>
<dc:description>Lipid liquid crystalline nanoparticles can find application as nanocarriers in several&#xd;
fields of the daily life but, very likely, the pharmaceutical arena is the most relevant.&#xd;
Indeed, several problems encountered in drugs administration (e.g. critical sideeffects&#xd;
from antitumor drugs) require alternative, less invasive, but simultaneously&#xd;
efficient therapeutic routes to be explored. Novel fields of personalized&#xd;
nanomedicine are developing in this direction. One of the most interesting is&#xd;
theranostic, which calls for the design of platforms capable of combining therapeutic&#xd;
and diagnostic functionalities.&#xd;
In this optic, we explored the potential of monoolein-based cubosomes and&#xd;
hexosomes as nanocarriers for theranostic purposes. Our work focussed on the&#xd;
design of lipid nanoparticles able to deliver antineoplastic drugs and imaging probes&#xd;
for fluorescent optical in vitro and in vivo imaging. We developed cubosome&#xd;
formulations loaded with antineoplastic drugs and useful for the fluorescence&#xd;
imaging of cells. Such formulations were also actively targeted to cancer cells and&#xd;
coupled with a NIR-emitting fluorophore, which was the promise for in vivo&#xd;
applications. We also investigated hexosomes with encouraging results&#xd;
encapsulating in their lipid matrix a BODIPY derivative with solvatochromic&#xd;
properties, helpful for the understanding of the dye localization.&#xd;
Importantly, we reported (manuscript submitted) the first proof-of-principle for in&#xd;
vivo fluorescence optical imaging application using monoolein-based cubosomes in&#xd;
a healthy mouse animal model.&#xd;
Finally, since relatively little is known about the interaction of cubosomes with&#xd;
biological systems, their effects on lipid droplets, mitochondria and lipid profile of&#xd;
HeLa cells were deeply studied.&#xd;
This thesis is divided in two main parts. The introduction section reports on the&#xd;
essential background of the research field, and it is followed by the publications&#xd;
(published or submitted) resulting from these three years of work.</dc:description>
<dc:date>2016-03-31</dc:date>
<dc:type>info:eu-repo/semantics/doctoralThesis</dc:type>
<dc:identifier>http://hdl.handle.net/11584/266769</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>numberofpages:138</dc:relation>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:publisher>Università degli Studi di Cagliari</dc:publisher>
<dc:rights>license:Non specificato</dc:rights>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>